Suchergebnisse - "Humans"

PubPharm (91.234)

1

Epilepsy with faint capillary malformation or reticulated telangiectasia associated with mosaic AKT3 pathogenic variants

enthalten in: American journal of medical genetics. Part A | 2024

von De Bortoli, M. | Ivars, M. | Revencu, N. | +10

2

Nobiletin targets SREBP1/ACLY to induce autophagy-dependent cell death of gastric cancer cells through PI3K/Akt/mTOR signaling pathway

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2024

von Chen, M. | Li, H. | Zheng, S. | +6

3

A novel DDIT3 activator dehydroevodiamine effectively inhibits tumor growth and tumor cell stemness in pancreatic cancer

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2024

von Zhu, S. | Qi, M. | Chen, M. | +4

4

Circulating tumor cells with metastasis-initiating competence survive fluid shear stress during hematogenous dissemination through CXCR4-PI3K/AKT signaling

enthalten in: Cancer letters | 2024

von Xin, Y. | Hu, B. | Li, K. | +6

5

Alisol B regulates AMPK/mTOR/SREBPs via directly targeting VDAC1 to alleviate hyperlipidemia

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2024

von Gao, G. | Zhao, J. | Ding, J. | +10

6

The rapid proximity labeling system PhastID identifies ATP6AP1 as an unconventional GEF for Rheb

enthalten in: Cell research | 2024

von Feng, R. | Liu, F. | Li, R. | +14

7

Regulation of inflammatory response by LINC00346 via miR-25-3p-mediated modulation of the PTEN/PI3K/AKT/NF-κB pathway

enthalten in: Biochemical and biophysical research communications | 2024

von Kim, M. | Lim, S. | Cho, D. | +3

8

Decabromodiphenyl ether exposure reduces dabrafenib sensitivity of papillary thyroid carcinoma harboring BRAFV600E mutation through the EGFR-CRAF-MAPK pathway : An in vitro study

enthalten in: Toxicology | 2024

von Wang, X. | Cui, X. | Wang, Y. | +3

9

Amino acid availability governs mTOR ubiquitination

enthalten in: Cell research | 2024

von Dai, X. | Yan, P. | Wei, W.

10

A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers

enthalten in: Cancer | 2024

von Algazi, A. | Moon, J. | Lao, C. | +14

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[9124]